Bacopa for memory and attention: test results
What studies of different bacopa extracts showed in memory and attention tests in adults.
Key points
- In healthy adults aged 18–55, B-Lit improved performance on a digit-sequence memory test by an average of 2.28 points more than placebo over 84 days. This is a possible improvement in that particular task. [1] See the evidence 1
- In adults aged 40–70 with memory and attention complaints, Bacumen showed no advantage over placebo in the primary word and attention tests over 12 weeks. Results differ by extract and task. [2] [3] See the evidence 1 2
- In one study of independently living people aged 65 and over, changes in word recall and time to complete a task with distracting information were described. The authors tested changes within groups, so these data cannot precisely estimate an advantage over placebo. [4] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
Bacopa studies used different extracts and tests. A result on one task does not describe all everyday abilities.
Key points
Why these conclusions
Individual memory and attention tests
Healthy adults aged 18–55 took 300 mg of B-Lit extract per day or placebo for 84 days. Digit-memory test performance rose by 2.45 points with the extract and 0.17 with placebo. [1]
In adults aged 40–70 with memory and attention complaints, Bacumen at 300 mg per day showed no advantage in the primary word-memory and attention tests over 12 weeks. The trial registration and article describe one study. [2] [3]
In people aged 65 and over without dementia or memory complaints, after 12 weeks of MediHerb the mean number of words recalled later changed from 6.4 to 7.6, and with placebo from 6.8 to 6.9. Time on a task with distracting information changed from 60.1 to 57.2 seconds and from 60.9 to 60.5 seconds, respectively; changes were statistically tested within groups. [4]
Certainty in these results is low, 2 out of 4. The studies tested specific tasks and did not measure overall success in study, work or daily activities. [1] [4] [2] [3]
In the Digit Span digit-sequence memory test, performance rose on average by 2.45 points with B-Lit and 0.17 with placebo over 84 days; the difference in change was 2.28 points.
| Parameter | Data |
|---|---|
| Result | In the Digit Span digit-sequence memory test, performance rose on average by 2.45 points with B-Lit and 0.17 with placebo over 84 days; the difference in change was 2.28 points. |
| Participants | Healthy adults aged 18–55 without sleep disturbances: 80 allocated to groups, 74 completed the study (38 B-Lit, 36 placebo) |
| Form | B-Lit, capsule containing 300 mg extract and 90 mg bacosides |
| Dose | 300 mg extract per day; one capsule in the morning after breakfast |
| Dose basis | 300 mg extract per day; one capsule in the morning after breakfast |
| Comparator | Placebo: capsule containing microcrystalline cellulose |
| Duration | 84 days |
| Certainty | 2/4: Risk of error: Only study completers were analyzed; several participants dropped out. Many measures were tested. Repeatability: One trial is presented for this comparison; studies of other extracts do not replicate it. Applicability: Specific tests were assessed, not overall success in study, work or daily activities. Precision: The sample was small; precision of the between-group difference is limited. Publication completeness: One trial is insufficient to assess whether negative results remained unpublished. |
| Volume of evidence | randomized study |
| Sources | [1] |
After 12 weeks, participants recalled words after a delay: an average of 7.6 versus 6.4 at baseline with bacopa and 6.9 versus 6.8 with placebo. The article statistically tested changes within each group; no separate estimate of the difference in changes between groups was provided.
| Parameter | Data |
|---|---|
| Result | After 12 weeks, participants recalled words after a delay: an average of 7.6 versus 6.4 at baseline with bacopa and 6.9 versus 6.8 with placebo. The article statistically tested changes within each group; no separate estimate of the difference in changes between groups was provided. |
| Participants | Independently living adults aged 65 and over without dementia or memory complaints: 54 allocated to groups, 48 completed (24 per group) |
| Form | MediHerb extract of above-ground bacopa parts, tablet; at least 50% bacosides A and B by the study method |
| Dose | 300 mg extract per day; one tablet |
| Dose basis | 300 mg extract per day; one tablet |
| Comparator | Tablets without extract, matching in appearance, smell and texture |
| Duration | 12 weeks of use after a six-week placebo run-in |
| Certainty | 2/4: Risk of error: The study was small; 48 of 54 participants completed it. For this measure the authors tested change within each group, limiting conclusions about an advantage over placebo. Repeatability: One trial is presented for this comparison; studies of other extracts do not replicate it. Applicability: Specific tests were assessed, not overall success in study, work or daily activities. Precision: The sample was small; precision of the between-group difference is limited. Publication completeness: One trial is insufficient to assess whether negative results remained unpublished. |
| Volume of evidence | randomized study |
| Sources | [4] |
Bacumen showed no advantage over placebo in the primary word learning and recall test over 12 weeks (p=0.391).
| Parameter | Data |
|---|---|
| Result | Bacumen showed no advantage over placebo in the primary word learning and recall test over 12 weeks (p=0.391). |
| Participants | Adults aged 40–70 with memory and attention complaints: 101 allocated to groups, 87 completed (40 Bacumen, 47 placebo) |
| Form | Bacumen extract in capsules |
| Dose | 300 mg extract per day; 150 mg twice daily with food |
| Dose basis | 300 mg extract per day; 150 mg twice daily with food |
| Comparator | Placebo: capsules matched in appearance and taste containing microcrystalline cellulose |
| Duration | 12 weeks |
| Certainty | 2/4: Risk of error: Of 101 participants, 87 completers were analyzed; dropout differed between groups (10 with Bacumen and 4 with placebo). Repeatability: One trial is presented for this comparison; studies of other extracts do not replicate it. Applicability: Specific tests were assessed, not overall success in study, work or daily activities. Precision: The sample was small; precision of the between-group difference is limited. Publication completeness: One trial is insufficient to assess whether negative results remained unpublished. |
| Volume of evidence | randomized study |
| Sources | [2] [3] |
Bacumen showed no advantage over placebo in the primary attention test over 12 weeks (p=0.713).
| Parameter | Data |
|---|---|
| Result | Bacumen showed no advantage over placebo in the primary attention test over 12 weeks (p=0.713). |
| Participants | Adults aged 40–70 with memory and attention complaints: 101 allocated to groups, 87 completed (40 Bacumen, 47 placebo) |
| Form | Bacumen extract in capsules |
| Dose | 300 mg extract per day; 150 mg twice daily with food |
| Dose basis | 300 mg extract per day; 150 mg twice daily with food |
| Comparator | Placebo: capsules matched in appearance and taste containing microcrystalline cellulose |
| Duration | 12 weeks |
| Certainty | 2/4: Risk of error: Of 101 participants, 87 completers were analyzed; dropout differed between groups (10 with Bacumen and 4 with placebo). Repeatability: One trial is presented for this comparison; studies of other extracts do not replicate it. Applicability: Specific tests were assessed, not overall success in study, work or daily activities. Precision: The sample was small; precision of the between-group difference is limited. Publication completeness: One trial is insufficient to assess whether negative results remained unpublished. |
| Volume of evidence | randomized study |
| Sources | [2] [3] |
In the Stroop test, the response-time measure changed from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. Less time means faster performance on a task with distracting information. The article’s statistical test concerns change within the group.
| Parameter | Data |
|---|---|
| Result | In the Stroop test, the response-time measure changed from 60.1 to 57.2 seconds with bacopa and from 60.9 to 60.5 seconds with placebo. Less time means faster performance on a task with distracting information. The article’s statistical test concerns change within the group. |
| Participants | Independently living adults aged 65 and over without dementia or memory complaints: 54 allocated to groups, 48 completed (24 per group) |
| Form | MediHerb extract of above-ground bacopa parts, tablet; at least 50% bacosides A and B by the study method |
| Dose | 300 mg extract per day; one tablet |
| Dose basis | 300 mg extract per day; one tablet |
| Comparator | Tablets without extract, matching in appearance, smell and texture |
| Duration | 12 weeks of use after a six-week placebo run-in |
| Certainty | 2/4: Risk of error: The study was small; 48 of 54 participants completed it. For this measure the authors tested change within each group, limiting conclusions about an advantage over placebo. Repeatability: One trial is presented for this comparison; studies of other extracts do not replicate it. Applicability: Specific tests were assessed, not overall success in study, work or daily activities. Precision: The sample was small; precision of the between-group difference is limited. Publication completeness: One trial is insufficient to assess whether negative results remained unpublished. |
| Volume of evidence | randomized study |
| Sources | [4] |
Information from the source
Nausea, abdominal pain, diarrhea, gas, headache, dizziness and rash have been described with bacopa use. In the Bacumen study, complaints, mainly digestive complaints and headache, occurred more often than with placebo; no serious adverse reactions were noted. Pregnant and breastfeeding women were excluded from the described B-Lit and Bacognize studies. These trials do not provide a basis for choosing a dose for them. Tolerability information here concerns the studied products and periods up to 12 weeks. [5] [2] [1] [6] [7]
Sources
- Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study. https://www.gavinpublishers.com/article/view/effect-of-bacopa-monnieri-extract-on-memory-and--cognitive-skills-in-adult-humans-a-randomized-double-blind-placebo-controlled-study
- The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/41091332/
- An examination into the effects of a Bacopa monnieri extract (Bacumen) on cognition and stress in healthy adults with subjective memory complaints: a randomised, double-blind, placebo-controlled trial — ANZCTR ACTRN12623000475640. https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12623000475640
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. https://pubmed.ncbi.nlm.nih.gov/18611150/
- Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial. https://www.gavinpublishers.com/article/pdf/efficacy-and-safety-of-bacopa-monnieri-extract-for-stress-management-and-sleep-quality-a-randomized-doubleblind-placebocontrolled-trial
- Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study. https://www.sciencedirect.com/science/article/pii/S1756464621003200
- Bacopa monnieri. https://www.ncbi.nlm.nih.gov/books/NBK603563/
Methodology: Subpages evidence-led supplement pipeline v1